Kimberly Lapham

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Electron Transfer

Tyrosine Kinase

Induced Pluripotent Stem Cells

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

This page only lists publications with an associated author ORCID identifier.

Publications

Lloyd Wei Tat Tang, Ethan DaSilva, Kimberly Lapham, R Scott Obach
Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Lloyd Wei Tat Tang, Ethan DaSilva, Kimberly Lapham, R Scott Obach
Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes. Drug metabolism and disposition: the biological fate of chemicals 52 (6) (2024)
Kimberly Lapham, Nicholas Ferguson, Mark Niosi, Theunis C Goosen
Clotrimazole Identified as a Selective UGT2B4 Inhibitor Using Canagliflozin-2'-O-Glucuronide Formation as a Selective UGT2B4 Probe Reaction . Drug metabolism and disposition: the biological fate of chemicals (2024)
Lloyd Wei Tat Tang, Ethan DaSilva, Kimberly Lapham, R Scott Obach
Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes. Drug metabolism and disposition: the biological fate of chemicals (2024)
Kimberly Lapham, Ernesto Callegari, Julie Cianfrogna, Jian Lin, Mark Niosi, Christine C Orozco, Raman Sharma, Theunis C Goosen
In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes. Drug metabolism and disposition: the biological fate of chemicals 48 (12) (2020)